Results from a meta-analysis in CLL: model supports MRD as primary endpoint in CLL chemo-immunotherapy trials – Lymphoma Hub
Lymphoma Hub |
Results from a meta-analysis in CLL: model supports MRD as primary endpoint in CLL chemo-immunotherapy trials
Lymphoma Hub This analysis was done to determine whether the treatment effect on MRD response in PB at the end of induction treatment with chemo-immunotherapy can predict treatment effect on PFS in patients with CLL. To this end, the investigators employed PB- MRD … |
